X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (73) 73
female (70) 70
adult (51) 51
infectious diseases (39) 39
pregnancy (39) 39
index medicus (31) 31
adolescent (27) 27
obstetrics & gynecology (27) 27
immunology (26) 26
prevention (23) 23
risk factors (22) 22
women (21) 21
human immunodeficiency virus--hiv (20) 20
sexually transmitted diseases (19) 19
tenofovir (19) 19
hiv (17) 17
article (16) 16
microbicide (16) 16
risk (16) 16
hiv infections - prevention & control (15) 15
health aspects (14) 14
infection (14) 14
microbiology (14) 14
preexposure prophylaxis (14) 14
sexual behavior (14) 14
dosage and administration (13) 13
pharmacokinetics (13) 13
young adult (13) 13
hiv prevention (12) 12
infant, newborn (12) 12
middle aged (12) 12
safety (12) 12
clinical trials (11) 11
logistic models (11) 11
male (11) 11
sexually transmitted diseases - prevention & control (11) 11
analysis (10) 10
anti-hiv agents - administration & dosage (9) 9
hiv-infection (9) 9
men (9) 9
microbicides (9) 9
prophylaxis (9) 9
public health (9) 9
sexually transmitted diseases - epidemiology (9) 9
sexually transmitted diseases - ethnology (9) 9
tenofovir - administration & dosage (9) 9
african americans (8) 8
hiv infection (8) 8
hiv infections - drug therapy (8) 8
public, environmental & occupational health (8) 8
rectum (8) 8
std (8) 8
vagina (8) 8
womens health (8) 8
acceptability (7) 7
adolescents (7) 7
aids/hiv (7) 7
condom use (7) 7
medication adherence (7) 7
medicine & public health (7) 7
minority women (7) 7
multivariate analysis (7) 7
research (7) 7
risk-taking (7) 7
sex (7) 7
acquired immune deficiency syndrome--aids (6) 6
adherence (6) 6
adhesion (6) 6
aids (6) 6
anti-hiv agents - pharmacokinetics (6) 6
cohort studies (6) 6
disease (6) 6
disease prevention (6) 6
emtricitabine (6) 6
gels (6) 6
gestational age (6) 6
infants (6) 6
mexican americans (6) 6
pharmacology (6) 6
pre-exposure prophylaxis (6) 6
recurrence (6) 6
sexually transmitted diseases--std (6) 6
social sciences, biomedical (6) 6
tenofovir - pharmacokinetics (6) 6
texas - epidemiology (6) 6
usage (6) 6
african americans - psychology (5) 5
african women (5) 5
anti-infective agents (5) 5
chlamydia infections - prevention & control (5) 5
complications and side effects (5) 5
confidence intervals (5) 5
counseling (5) 5
follow-up studies (5) 5
health psychology (5) 5
incidence (5) 5
pregnant women (5) 5
randomized controlled trials as topic (5) 5
research article (5) 5
risk reduction behavior (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 02/2015, Volume 372, Issue 6, pp. 509 - 518
Preventing HIV-1 infection is a high global priority. This study assessed prevention strategies in young women in South Africa, Uganda, and Zimbabwe using oral... 
TRIALS | MEDICINE, GENERAL & INTERNAL | TRANSMISSION | ANTIRETROVIRAL PROPHYLAXIS | MICROBICIDE | PREVENTION | ADHERENCE | GEL | HIV Infections - prevention & control | Humans | Middle Aged | Drug Resistance, Viral | Administration, Intravaginal | Deoxycytidine - blood | Adenine - blood | Tenofovir | Young Adult | Adenine - adverse effects | Adult | Deoxycytidine - adverse effects | Female | Organophosphonates - blood | Surveys and Questionnaires | Anti-Retroviral Agents - blood | Drug Therapy, Combination | Emtricitabine | Adenine - analogs & derivatives | HIV Seropositivity | Administration, Oral | HIV-1 - drug effects | Deoxycytidine - administration & dosage | Anti-Retroviral Agents - adverse effects | Organophosphonates - adverse effects | Africa South of the Sahara | Adenine - administration & dosage | Pre-Exposure Prophylaxis | Organophosphonates - administration & dosage | Medication Adherence | Anti-Retroviral Agents - administration & dosage | Adolescent | HIV Infections - complications | Deoxycytidine - analogs & derivatives | Women | Care and treatment | HIV infection in women | Dosage and administration | HIV infection | Health aspects | Risk factors | Intervention | Creatinine | Antiretroviral drugs | Motivation | Human immunodeficiency virus--HIV | Prophylaxis | Vagina | Infections | Preventive medicine
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0181607
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e60147
Objective: Rectal microbicides are needed to reduce the risk of HIV acquisition associated with unprotected receptive anal intercourse. The MTN-007 study was... 
TRIALS | HIV-INFECTION | MICROBICIDE | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | ULCERATIVE-COLITIS | MEN | SEX | RISK | MODEL | ANAL INTERCOURSE | HIV Infections - prevention & control | Intestinal Mucosa - metabolism | Oligonucleotide Array Sequence Analysis | Rectum - pathology | Humans | Middle Aged | Administration, Rectal | Male | Intestinal Mucosa - drug effects | Anti-HIV Agents - administration & dosage | Tenofovir | Young Adult | Adenine - adverse effects | Rectum - drug effects | Adult | Female | Adenine - analogs & derivatives | Double-Blind Method | Gels | Anti-HIV Agents - adverse effects | Rectum - metabolism | Organophosphonates - adverse effects | Transcriptome - drug effects | Adenine - administration & dosage | Organophosphonates - administration & dosage | Dosage and administration | Safety and security measures | Flow cytometry | Mucosa | Cellulose | Microflora | Lymphocytes T | Acceptability | Prevention | Mens health | Randomization | Microbicides | Acquired immune deficiency syndrome--AIDS | Quality | Human immunodeficiency virus--HIV | Safety | Medical research | Health risks | Risk reduction | Histology | Inflammation | FDA approval | Gene expression | Nonoxynol | Inflammatory bowel disease | Birth control | Cytometry | Protein arrays | DNA microarrays | Rectum | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal Article
AIDS and Behavior, ISSN 1090-7165, 2/2018, Volume 22, Issue 2, pp. 402 - 411
The MTN-008 trial was the first multi-dose study conducted to evaluate the safety of a microbicide gel (2:1 randomized to tenofovir 1% or hydroxycellulose... 
Tenofovir | Pregnant | Public Health | Medicine & Public Health | Microbicide | Infectious Diseases | Health Psychology | HIV prevention | Breastfeeding | SAFETY | RAKAI | SOCIAL SCIENCES, BIOMEDICAL | ACQUISITION | UGANDA | TRIAL | TRANSMISSION | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | INFECTION | PREEXPOSURE PROPHYLAXIS | ASSOCIATION | HIV Infections - prevention & control | Pregnant Women - psychology | United States | Humans | Administration, Intravaginal | Treatment Outcome | Tenofovir - administration & dosage | Patient Acceptance of Health Care - psychology | Alabama | Pregnancy | Young Adult | Medication Adherence | Anti-Infective Agents - administration & dosage | Anti-Retroviral Agents - administration & dosage | Adolescent | Adult | Female | Vaginal Creams, Foams, and Jellies | Philadelphia | Cohort Studies | Prevention | Complications and side effects | Dosage and administration | Research | HIV infection | Drug abuse | Discomfort | Infants | Gestation | Acceptability | Pain | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Questionnaires | Fetus | Qualitative analysis | Product safety | Drug dosages | Leakage | Women | Qualitative research | Statistical analysis | Fetuses | Vagina | Pharmacology | Adhesion | Babies | Prescription drugs | Pharmacokinetics
Journal Article
AIDS and Behavior, ISSN 1090-7165, 11/2016, Volume 20, Issue 11, pp. 2654 - 2661
VOICE—a phase 2B, placebo-controlled, randomized trial testing daily use of an antiretroviral tablet (tenofovir or Truvada) or daily use of tenofovir gel in... 
Public Health | sub-Saharan Africa | Self-reports of adherence | Medicine & Public Health | Microbicide trials | Infectious Diseases | Health Psychology | SOUTH-AFRICA | AFRICAN WOMEN | EFFICACY | MICROBICIDE | SOCIAL SCIENCES, BIOMEDICAL | PLACEBO GEL | ACCEPTABILITY | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HIV-INFECTION | NONADHERENCE | PREEXPOSURE PROPHYLAXIS | HIV Infections - blood | HIV Infections - prevention & control | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - pharmacokinetics | Medication Adherence - psychology | Gels | Administration, Oral | Deception | Humans | Middle Aged | Tenofovir - administration & dosage | Self Disclosure | Tenofovir - pharmacokinetics | Pre-Exposure Prophylaxis | Anti-HIV Agents - administration & dosage | Young Adult | Anti-HIV Agents - pharmacokinetics | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - administration & dosage | Adult | Female | South Africa | Uganda | Zimbabwe | Prevention | Anti-infective agents | Usage | Patient compliance | Health aspects | HIV infection | Drugs | Participation | Antiretroviral drugs | Clinical trials | Vagina | Antimicrobial agents | Disclosure | Reporting | Adhesion | Disease prevention | Tenofovir | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Self disclosure | Methodology (Data collection) | Females
Journal Article
Sexually Transmitted Diseases, ISSN 0148-5717, 03/2017, Volume 44, Issue 3, pp. 135 - 140
Journal Article
eLife, ISSN 2050-084X, 03/2015, Volume 4, Issue 4, pp. 1 - 49
Journal Article
AIDS and Behavior, ISSN 1090-7165, 3/2018, Volume 22, Issue 3, pp. 986 - 995
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 01/2016, Volume 19, Issue 1, pp. 20642 - n/a
Journal Article